D. Bryla

发表

The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam.

D. D. Trach, J. Robbins, F. Lin, 2000, The American journal of tropical medicine and hygiene.

Serum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoid

S. Szu, A. Fattom, J. Mestecky, 1990, Infection and immunity.

The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children.

J. Shiloach, D. D. Trach, S. Szu, 2001, The New England journal of medicine.

Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.

S. Szu, R. Schneerson, J. Robbins, 2003, The New England journal of medicine.

Treatment with Succinic Anhydride Improves the Immunogenicity ofShigella flexneri Type 2a O-Specific Polysaccharide–Protein Conjugates in Mice

J. Shiloach, S. Bystrický, R. Schneerson, 1999, Infection and Immunity.

Phase 1 Evaluation of Vibrio choleraeO1, Serotype Inaba, Polysaccharide-Cholera Toxin Conjugates in Adult Volunteers

David N. Taylor, S. Szu, J. Robbins, 1998, Infection and Immunity.

Effect of Dosage on Immunogenicity of a Vi Conjugate Vaccine Injected Twice into 2- to 5-Year-Old Vietnamese Children

J. Shiloach, D. D. Trach, S. Szu, 2004, Infection and Immunity.

Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity

Devi, S. Devi, R. Schneerson, 1991, Infection and immunity.

Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide.

J. Shiloach, J. Muir-Nash, D. Bryla, 1988, The Journal of pediatrics.

Investigational vaccine for Escherichia coli O157: phase 1 study of O157 O-specific polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugates in adults.

J. C. Parke, S. Szu, J. Robbins, 1998, The Journal of infectious diseases.

Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.

R. Schneerson, J. Robbins, D. Bryla, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis.

J. Robbins, D. Bryla, J. Taranger, 1997, The Journal of pediatrics.

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.

R. Thapa, R. Schneerson, J. Robbins, 1987, The New England journal of medicine.

Phase 1 and Phase 2 Studies of Salmonella enterica Serovar Paratyphi A O-Specific Polysaccharide-Tetanus Toxoid Conjugates in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

D. D. Trach, S. Szu, Jianping Li, 2000, Infection and Immunity.

Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls

J. Shiloach, S. Szu, J. Robbins, 1996, Infection and immunity.

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

J. Shiloach, R. Schneerson, J. Robbins, 1991, Infection and immunity.

Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate Vaccines

A. Fattom, R. Schneerson, J. Robbins, 1995, Annals of the New York Academy of Sciences.

Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate

I. Pastan, J. Shiloach, A. Fattom, 1992, Infection and immunity.

Safety and Immunogenicity of Vi Conjugate Vaccines for Typhoid Fever in Adults, Teenagers, and 2- to 4-Year-Old Children in Vietnam

D. D. Trach, S. Szu, R. Schneerson, 1999, Infection and Immunity.

Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A

I. Pastan, J. Shiloach, A. Fattom, 1993, Infection and immunity.

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis.

R. Schneerson, J. Robbins, D. Bryla, 2000, The Journal of infectious diseases.

Immunity to pertussis. Not all virulence factors are protective antigens.

R. Schneerson, J. Robbins, D. Bryla, 1998, Advances in experimental medicine and biology.

polysaccharide-protein conjugate vaccines. Escherichia coli O157 O-specific immunological properties in mice of Preparation, characterization, and

J. Shiloach, S. Szu, J. Robbins, 2013 .

Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines

J. Shiloach, S. Szu, J. Robbins, 1994, Infection and immunity.

Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age.

J. C. Parke, R. Schneerson, J. Robbins, 1991, The Journal of pediatrics.

Clostridium difficile Recombinant Toxin A Repeating Units as a Carrier Protein for Conjugate Vaccines: Studies of Pneumococcal Type 14, Escherichia coli K1, andShigella flexneri Type 2a Polysaccharides in Mice

R. Schneerson, J. Robbins, D. Bryla, 2000, Infection and Immunity.

Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids

J. Shiloach, Y. Lerman, D. Cohen, 1993, Infection and immunity.

Safety and immunogenicity of Staphylococcus aureus type 5 capsular polysaccharide-Pseudomonas aeruginosa recombinant exoprotein A conjugate vaccine in patients on hemodialysis.

J. Shiloach, A. Fattom, R. Schneerson, 1996, Journal of the American Society of Nephrology : JASN.

Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.

R. Schneerson, J. Robbins, D. Bryla, 1988, The Journal of pediatrics.

Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate.

R. Schneerson, J. Robbins, D. Bryla, 1989, The Journal of pediatrics.

Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi

S. Szu, R. Schneerson, J. Robbins, 1989, Infection and immunity.

Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines

J. Shiloach, S. Szu, D. N. Taylor, 1994, Infection and immunity.

Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker

J. Shiloach, S. Bystrický, S. Szu, 1997, Infection and immunity.

Immunization of children with pertussis toxoid decreases spread of pertussis within the family.

R. Schneerson, J. Robbins, D. Bryla, 1998, The Pediatric infectious disease journal.

Synthesis and physicochemical and immunological characterization of pneumococcus type 12F polysaccharide-diphtheria toxoid conjugates

S. Szu, A. Fattom, A. Sutton, 1988, Infection and immunity.

Evaluation of monophosphoryl lipid A (MPL) as an adjuvant. Enhancement of the serum antibody response in mice to polysaccharide-protein conjugates by concurrent injection with MPL.

S. Szu, A. Fattom, R. Schneerson, 1991, Journal of immunology.

Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid

J. Shiloach, S. Szu, R. Schneerson, 1991, Infection and immunity.

Comparative immunogenicity of conjugates composed of Escherichia coli O111 O-specific polysaccharide, prepared by treatment with acetic acid or hydrazine, bound to tetanus toxoid by two synthetic schemes

R. Gupta, S. Szu, J. Robbins, 1995, Infection and immunity.

Vietnam Teenagers , and 2-to 4-Year-Old Children in Vaccines for Typhoid Fever in Adults , Safety and Immunogenicity of Vi Conjugate

D. D. Trach, S. Szu, R. Schneerson, 1999 .

Safety and Immunogenicity of ImprovedShigella O-Specific Polysaccharide-Protein Conjugate Vaccines in Adults in Israel

J. Shiloach, R. Schneerson, J. Robbins, 2001, Infection and Immunity.

Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.

R. Schneerson, J. Robbins, R. Dagan, 1999, The Journal of infectious diseases.

Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.

R. Schneerson, J. Robbins, D. Bryla, 1991, The Pediatric infectious disease journal.

Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants.

J. Robbins, D. Bryla, J. Taranger, 1997, The Pediatric infectious disease journal.

Risks of amniocentesis.

D. Bryla, C. Lowe, D. Seigel, 1979, Lancet.

Immunity to Pertussis

R. Schneerson, J. Robbins, D. Bryla, 1998 .

Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy.

P. Scheidt, H. Hoffman, B. Graubard, 1991, Pediatrics.

Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia.

D. Bryla, A. Brown, M. H. Kim, 1985, Pediatrics.

Development, Design, and Sample Composition

D. Bryla, 1985, Pediatrics.

Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Development, design, and sample composition.

D. Bryla, 1985, Pediatrics.